Phase 2 results of relacorilant + nabpaclitaxel in patients with recurrent, platinum-resistant ovarian cancer with and without prior bevacizumab Meeting Abstract


Authors: Colombo, N.; Van Gorp, T.; Matulonis, U.; Oaknin, A.; Grisham, R.; Fleming, G.; Olawaiye, A.; Tudor, I. C.; Pashova, H.; Lorusso, D.
Abstract Title: Phase 2 results of relacorilant + nabpaclitaxel in patients with recurrent, platinum-resistant ovarian cancer with and without prior bevacizumab
Meeting Title: IGCS 2022 Annual Meeting
Journal Title: International Journal of Gynecological Cancer
Volume: 32
Issue: Suppl. 3
Meeting Dates: 2022 Sep 29-Oct 1
Meeting Location: New York, NY
ISSN: 1048-891X
Publisher: Lippincott Williams & Wilkins  
Date Published: 2022-12-01
Start Page: A32
End Page: A33
Language: English
ACCESSION: WOS:000899252300059
DOI: 10.1136/ijgc-2022-igcs.60
PROVIDER: wos
Notes: Meeting Abstract: 16/#430 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Rachel Nicole Grisham
    169 Grisham